Surgery Partners, Inc.

NasdaqGS:SGRY Stock Report

Market Cap: US$2.7b

Surgery Partners Future Growth

Future criteria checks 4/6

Surgery Partners is forecast to grow earnings and revenue by 83.3% and 9.3% per annum respectively. EPS is expected to grow by 85.1% per annum. Return on equity is forecast to be 7.4% in 3 years.

Key information

83.3%

Earnings growth rate

85.1%

EPS growth rate

Healthcare earnings growth18.9%
Revenue growth rate9.3%
Future return on equity7.4%
Analyst coverage

Good

Last updated06 Jan 2025

Recent future growth updates

Recent updates

Market Cool On Surgery Partners, Inc.'s (NASDAQ:SGRY) Revenues Pushing Shares 28% Lower

Dec 08
Market Cool On Surgery Partners, Inc.'s (NASDAQ:SGRY) Revenues Pushing Shares 28% Lower

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Nov 11
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Market Cool On Surgery Partners, Inc.'s (NASDAQ:SGRY) Revenues

Oct 24
Market Cool On Surgery Partners, Inc.'s (NASDAQ:SGRY) Revenues

Surgery Partners (NASDAQ:SGRY) Has Some Way To Go To Become A Multi-Bagger

Oct 05
Surgery Partners (NASDAQ:SGRY) Has Some Way To Go To Become A Multi-Bagger

Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Jul 25
Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Jul 13
Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

Jun 21
Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Apr 24
Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Mar 18
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Feb 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Dec 19
The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Oct 26
Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Sep 17
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

Aug 26
Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Jul 21
The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

Jun 15
Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

May 26
A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Apr 14
There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Mar 24
Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jan 24
Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

Sep 26
We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Aug 15
The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M

Aug 02

Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders

Jul 02

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Jun 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Earnings and Revenue Growth Forecasts

NasdaqGS:SGRY - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20274,120178N/AN/A1
12/31/20263,69914232044310
12/31/20253,38410228942812
12/31/20243,078-3419131611
9/30/20242,985-61163251N/A
6/30/20242,889-34204291N/A
3/31/20242,7951175260N/A
12/31/20232,743-12205294N/A
9/30/20232,715-34147238N/A
6/30/20232,662-5473164N/A
3/31/20232,609-9267154N/A
12/31/20222,539-5578159N/A
9/30/20222,442-3199171N/A
6/30/20222,381-2986157N/A
3/31/20222,309-3855117N/A
12/31/20212,225-813087N/A
9/30/20212,163-861876N/A
6/30/20212,100-1353788N/A
3/31/20211,932-150222268N/A
12/31/20201,860-156204247N/A
9/30/20201,829-179212263N/A
6/30/20201,785-132232293N/A
3/31/20201,856-11965138N/A
12/31/20191,831-11056130N/A
9/30/20191,805-23886150N/A
6/30/20191,786-24367122N/A
3/31/20191,777-24194135N/A
12/31/20181,772-238105145N/A
9/30/20181,732-122118154N/A
6/30/20181,597-125N/A134N/A
3/31/20181,443-102N/A116N/A
12/31/20171,312-79N/A121N/A
9/30/20171,159-22N/A99N/A
6/30/20171,1357N/A108N/A
3/31/20171,13914N/A135N/A
12/31/20161,1219N/A125N/A
9/30/20161,0799N/A117N/A
6/30/20161,0399N/A128N/A
3/31/20169811N/A100N/A
12/31/20159361N/A84N/A
9/30/2015855-70N/A53N/A
6/30/2015696-73N/A38N/A
3/31/2015544-69N/A27N/A
12/31/2014394-66N/A22N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SGRY is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: SGRY is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: SGRY is expected to become profitable in the next 3 years.

Revenue vs Market: SGRY's revenue (9.3% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: SGRY's revenue (9.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SGRY's Return on Equity is forecast to be low in 3 years time (7.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 23:21
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Surgery Partners, Inc. is covered by 24 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven ValiquetteBarclays
Sarah JamesBarclays
Andrew MokBarclays